| First Author | Puggioni V | Year | 2020 |
| Journal | Biochim Biophys Acta Proteins Proteom | Volume | 1868 |
| Issue | 10 | Pages | 140472 |
| PubMed ID | 32553892 | Mgi Jnum | J:343397 |
| Mgi Id | MGI:7565904 | Doi | 10.1016/j.bbapap.2020.140472 |
| Citation | Puggioni V, et al. (2020) Biochemical characterization of mouse d-aspartate oxidase. Biochim Biophys Acta Proteins Proteom 1868(10):140472 |
| abstractText | D-amino acids research field has recently gained an increased interest since these atypical molecules have been discovered to play a plethora of different roles. In the mammalian central nervous system, d-aspartate (D-Asp) is critically involved in the regulation of glutamatergic neurotransmission by acting as an agonist of NMDA receptor. Accordingly, alterations in its metabolism have been related to different pathologies. D-Asp shows a peculiar temporal pattern of emergence during ontogenesis and soon after birth its brain levels are strictly regulated by the catabolic enzyme d-aspartate oxidase (DASPO), a FAD-dependent oxidase. Rodents have been widely used as in vivo models for deciphering molecular mechanisms and for testing novel therapeutic targets and drugs, but human targets can significantly differ. Based on these considerations, here we investigated the structural and functional properties of the mouse DASPO, in particular kinetic properties, ligand and flavin binding, oligomerization state and protein stability. We compared the obtained findings with those of the human enzyme (80% sequence identity) highlighting a different oligomeric state and a lower activity for the mouse DASPO, which apoprotein species exists in solution in two forms differing in FAD affinity. The features that distinguish mouse and human DASPO suggest that this flavoenzyme might control in a distinct way the brain D-Asp levels in different organisms. |
